PhD, Walden University; MPH, University of Pittsburgh
Public health management; clinical drug development; impact of federal regulation on clinical research activities; health economics and outcomes research
Dr. Panas started working in public health more than 20 years ago and transitioned into pharmaceutical research about 15 years ago. He currently serves as director of medical and scientific affairs for a biopharmaceutical company and is a contributing faculty member at Walden University. Over the years, Dr. Panas has monitored and managed numerous clinical trials and worked on New Drug Applications (U.S.) and Marketing Authorization Applications (EU). He has contributed to and presented several posters, oral presentations, and publications. He has been an officer or board member for several organizations and is currently a member of the American Public Health Association, American Society for Clinical Pathology, Association of Clinical Research Professionals, Drug Information Association, International Health Economics Association, International Society for Pharmacoeconomics and Outcomes Research, and Who’s Who in Science and Healthcare.